✓ Medically reviewed by Dr. Anjmun Sharma, MD · Updated 2026-06-09

GLP-1 Medications and IBS: What to Consider When Your Gut Is Already Sensitive

A sensitive gut does not automatically rule out GLP-1 treatment, but it does make careful physician screening essential.

GLP-1 medications such as semaglutide and tirzepatide slow digestion, which helps with weight loss but can also stir up symptoms in people with irritable bowel syndrome. Many patients with IBS still use these medications successfully. The keys are careful screening before the first dose, a conservative dosing plan, and ongoing physician supervision, all of which matter more when your gut is already sensitive.

A serene, comfortable setting

Why GLP-1 medications affect digestion

Semaglutide and tirzepatide work in part by slowing gastric emptying, which keeps you full longer and lowers appetite. That same mechanism explains the most common side effects: nausea, bloating, constipation, and sometimes diarrhea. For most patients these effects are mild and tend to fade as the body adjusts to each dose.

If you live with IBS, your gut already reacts strongly to changes in motility, meal size, and stress. A medication that deliberately changes how quickly food moves through your system can feel more noticeable for you than for someone without a sensitive digestive tract. That does not automatically rule out treatment, it simply raises the bar for careful evaluation.

IBS subtypes change the conversation

IBS is not one condition. Some people deal mostly with constipation (IBS-C), others with diarrhea (IBS-D), and many alternate between the two. Because GLP-1 medications slow digestion, someone with constipation-predominant IBS may need a more cautious plan for hydration, fiber, and dose increases. Someone with diarrhea-predominant IBS may notice a different pattern entirely, and responses vary widely from person to person.

Ready to start?

$199 Skeptics’ Trial, see if it works for you

One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.

Start the 30-day trial

Research on GLP-1 medications specifically in people with IBS is still limited, so honest expectations matter. A physician's job is to weigh your subtype, your symptom history, and your current stability before deciding whether these medications are a reasonable fit, and to adjust the plan if your gut pushes back.

Why screening matters before your first dose

A real medical review does more than confirm your weight. It should cover how often you flare, what triggers your symptoms, and whether anything in your history points to a condition that deserves evaluation first. New or changing gut symptoms should never simply be assumed to be IBS. A thorough screening visit typically covers:

How New Hope Weight Loss approaches sensitive-gut patients

At New Hope Weight Loss in Costa Mesa, every patient starts with a $119 medical review with Dr. Anjmun Sharma, MD, available in person or through telehealth. Patients with IBS receive a plan built around slower, supervised dose adjustments and regular check-ins, so side effects are addressed early rather than endured silently. Compounded semaglutide starts at $166 per month and compounded tirzepatide at $233 per month, and a $199 one-month Skeptics' Trial, which includes a free B-12/lipotropic injection, gives cautious patients a low-commitment way to see how their body responds. These compounded medications are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA, which is one more reason physician supervision is built into every plan.

What you can start today at New Hope Weight Loss

After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.

Ready for an honest, physician-supervised plan?

A $119 review with Dr. Sharma is the first step, no pressure. Take the 2-minute quiz or call us.

Call (657) 837-3342

Frequently asked questions

Can I take GLP-1 medications if I have IBS?

Many people with IBS use GLP-1 medications successfully, but the decision belongs to a physician who knows your history. A screening visit reviews your subtype, current symptoms, and medications before any prescription is written.

Will semaglutide make my IBS symptoms worse?

It can change bowel habits at first because it slows digestion, and people with IBS may notice this more than others. Side effects often ease as the body adjusts, and your physician can slow the dose schedule if your gut struggles.

Is semaglutide or tirzepatide gentler on a sensitive gut?

Both medications cause similar digestive side effects, and individual responses vary widely. There is no universal answer, which is why the choice is made by your physician based on your history rather than a general rule.

What should I tell the doctor during screening if I have IBS?

Share your IBS subtype, how often you flare, your known triggers, and every medication or supplement you take. Also mention any red flags like bleeding or unintentional weight loss, since those need evaluation before starting.

Are the compounded GLP-1 medications at New Hope Weight Loss FDA-approved?

No. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. Brand medications such as Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved.

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.